CSL Limited (CMXHF)
OTCMKTS · Delayed Price · Currency is USD
174.00
+0.46 (0.27%)
Jul 30, 2025, 10:30 AM EDT
CSL Limited Market Cap
CSL Limited has a market cap or net worth of $85.44 billion as of July 30, 2025. Its market cap has decreased by -14.71% in one year.
Market Cap
85.44B
Enterprise Value
98.51B
Revenue
15.23B
Ranking
n/a
PE Ratio
31.09
Stock Price
$174.00
Market Cap Chart
Since June 2, 1994, CSL Limited's market cap has increased from 230.16M to 85.44B, an increase of 37,023.32%. That is a compound annual growth rate of 20.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2025 | 85.72B | 1.60% |
| Dec 31, 2024 | 84.38B | -10.61% |
| Dec 29, 2023 | 94.40B | 0.09% |
| Dec 30, 2022 | 94.31B | -6.81% |
| Dec 31, 2021 | 101.20B | 1.81% |
| Dec 31, 2020 | 99.40B | 13.04% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.81B |
| Veradigm | 794.80M |
| Nika Pharmaceuticals | 708.22M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 586.78M |
| Glass House Brands | 435.01M |
| Northwest Biotherapeutics | 372.10M |
| CytoDyn | 355.85M |